Skip to main content

Vascular Pathology of Antiphospholipid Antibody Syndrome

  • Chapter
  • 747 Accesses

Keywords

  • Systemic Lupus Erythematosus
  • Vascular Pathology
  • Thrombotic Microangiopathy
  • Pulmonary Arteriole
  • Glomerular Capillary Loop

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hunt BJ, Khamashta MA. Antiphospholipid antibodies and the endothelium. Curr Rheumatol Rep 2000;2:252–255.

    PubMed  CAS  Google Scholar 

  2. Halevy D, Radhakrishnan J, Markowitz G, Appel G. Thrombotic microangiopathies. Crit Care Clin 2003;18:309–320.

    CrossRef  Google Scholar 

  3. Raschi E, Testoni C, Borghi MO, Fineschi S, Meroni PL. Endothelium activation in the antiphospholipid antibody syndrome. Biomed Pharmacother 2003;57:282–286.

    CrossRef  PubMed  CAS  Google Scholar 

  4. Lie JT. Vasculopathy of the antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort. Lupus 1996;368:71.

    Google Scholar 

  5. Sherer Y, Shoenfeld Y. Antiphospholipid antibody syndrome, antiphospholipid antibodies and atherosclerosis. Curr Atheroscler Rep 2001;3:328–333.

    PubMed  CAS  Google Scholar 

  6. Hughson MD, Nadasdy T, McCarty GA, Sholer C, Min KW, Silva F. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kid Dis 1992;20:150–158.

    PubMed  CAS  Google Scholar 

  7. Hughson MD, McCarty GA, Sholer CM, Brumback RA. Thrombotic cerebral arteriopathy in patients with the antiphospholipid syndrome. Mod Pathol 1993;6:644–653.

    PubMed  CAS  Google Scholar 

  8. Hughson MD, McCarty GA, Brumback RA. Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum Pathol 1995;26:716–724.

    CrossRef  PubMed  CAS  Google Scholar 

  9. Pierangeli SS, Harris EN. Probing antiphospholipid antibody-mediated thrombosis-the interplay between anticardiolipin and antiendothelial cell antibodies. Lupus 2003;12:539–545.

    CrossRef  PubMed  CAS  Google Scholar 

  10. Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsoupoulos HM. Antiphospholipid antibody syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies. Arthritis Rheum 2004;50:2569–2579.

    CrossRef  PubMed  Google Scholar 

  11. Alarcon-Segovia D, Cardiel MH, Reyes E, et al. Antiphospholipid arterial vasculopathy. J Rheum 1989;16:762–767.

    PubMed  CAS  Google Scholar 

  12. Goldberger E, Elder RC, Schwartz RA, Phillips PE. Vasculitis in the antiphospholipid syndrome. A cause of ischemia responding to corticosteroids. Arthritis Rheum 1992;35:569–572.

    PubMed  CAS  Google Scholar 

  13. Westerman EM, Miles JM, Backonja M, Sundstrom WR. Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Evidence for endothelial injury as the primary event. Arthritis Rheum 1992;35:1038–1041.

    PubMed  CAS  Google Scholar 

  14. Winklemann RK, Alegre VA. Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant. J Am Acad Dermatol 1988;19:117–124.

    CrossRef  Google Scholar 

  15. Wilson WA, Gharavi AE, Koike T, et al. International concensus statement on preliminary criteria for definite antiphospholipid antibody syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309–1311.

    CrossRef  PubMed  CAS  Google Scholar 

  16. Brandt JT, Triplett DA, Alving B, Scharrer I, on behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody Section of the Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis. Criteria for the diagnosis of lupus anticoagulant: an update. Thromb Haemost 1995;74:1185–1190.

    PubMed  CAS  Google Scholar 

  17. McIntyre JA, Wagenknecht DR, Waxman DW. Frequency and specificities of antiphospholipid antibodies in volunteer blood donors. Immunobiology 2003;207:59–63.

    CrossRef  PubMed  CAS  Google Scholar 

  18. Frances C, Tribout B, Boisnic S. Cutaneous necrosis associated with the lupus anticoagulant. Dermatologica 1989;178:194–201.

    CrossRef  PubMed  CAS  Google Scholar 

  19. Creamer D, Black MM, Colange E. Reactive angioendotheliomatosis in association with antiphospholipid antibody syndrome. J Am Acad Dermatol 2000;42:903–906.

    CrossRef  PubMed  CAS  Google Scholar 

  20. Dodd HJ, Sarkany I, O’Shaughnessy D. Widespread cutaneous necrosis associated with the lupus anticoagulant. Clin Exp Dermatol 1985;10:581–586.

    CrossRef  PubMed  CAS  Google Scholar 

  21. Smith KJ, Skelton HG, James WD, et al. Cutaneous histopathologic findings in ‘antiphospholipid syndrome’: correlation with disease, including human immundeficiency virus disease. Arch Dermatol 1990;126:1176–1183.

    CrossRef  PubMed  CAS  Google Scholar 

  22. O’Neill A, Gatenby PA, McGaw B, Painter DM, McKenzie PR. Widespread cutaneous necrosis associated with cardiolipin antibodies. J Am Acad Dermatol 1990;22:356–359.

    PubMed  CAS  Google Scholar 

  23. Wolf P, Soyes HP, Aver Grunbach P. Widespread cutaneous necrosis in a patient with rheumatoid arthritis associated with anticardiolipin. Arch Dermatol 1991;127:1739–1740.

    CrossRef  PubMed  CAS  Google Scholar 

  24. Elkayam O, Yaron M, Brasoush E, Carpi D. Rheumatoid nodules in a patient with primary antiphosphlipid antibody syndrome (Hughes’ Syndrome). Lupus 1998;7:488–491.

    CrossRef  PubMed  CAS  Google Scholar 

  25. Macucci M, Dotti MT, Battistini S, et al. Primary antiphospholipid syndrome: two case reports, one with histological examination of skin, peripheral nerve and muscle. Acta Neurol 1994;16:87–96.

    CAS  Google Scholar 

  26. Lalova A, Popov I, Dourmishev A, Baleva M, Nikolov K. Dramatic vasculopathy in a patient with antiphospholipid syndrome [letter]. Acta Derm Venerol 1996; 76:406

    PubMed  CAS  Google Scholar 

  27. Abernethy ML, McGuinn JL, Callen JP. Widespread cutaneous necrosis as the initial manifestation of the antiphospholipid antibody syndrome. J Rheumatol 1995;22:1380–1383.

    PubMed  CAS  Google Scholar 

  28. Katayama I, Nishioka K, Otoyama K. Clinical analysis of anti-cardiolipin.beta 2 glycoprotein 1 antibody positive patients in anti-phospholipid syndrome. J Dermatol Sci 1995;9:215–220

    CrossRef  PubMed  CAS  Google Scholar 

  29. Frances C, Piette JC. Cutaneous manifestation of Hughes syndrome occurring in the context of lupus erythematosus. Lupus 1997;6:139–144.

    PubMed  CAS  Google Scholar 

  30. van Genderen PJ, Michiels JJ. Erythromelagia: a pathogomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera. Semin Thromb Hemost 1997;23:357–363.

    CrossRef  PubMed  Google Scholar 

  31. McCarty GA. Indiana Antiphospholipid Antibody Database, unpublished data.

    Google Scholar 

  32. Coates T, Kirkland GS, Dymock RB, et al. Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis 1998;32:384–391.

    PubMed  CAS  Google Scholar 

  33. Grone HJ. Systemic lupus erythematosus and antiphospholipid syndrome. Pathologe 1996;17:405–416.

    CrossRef  PubMed  CAS  Google Scholar 

  34. Hill VA, Whittaker SJ, Hunt BJ, Liddell K, Spittle, MF, Smith NP. Cutaneous necrosis associated with the antiphospholipid syndrome and mycosis fungoides. Br J Dermatol 1994;130:92–96.

    PubMed  CAS  Google Scholar 

  35. Kniaz D, Eisenberg GM, Elrad H, Johnson CA, Valaitis J, Bregman H. Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies. Am J Nephrol 1992;12:126–128.

    PubMed  CAS  Google Scholar 

  36. Alvarez-Blanco A, Egurbide-Arberas MV, Aguirre-Errasti C. Severe valvular heart disease in a patient with primary antiphospholipid syndrome. Lupus 1994;3:433–434.

    PubMed  CAS  Google Scholar 

  37. Trent K, Neustater BR, Lottenberg R. Chronic relapsing thrombotic thrombocytopenic purpura and antiphospholipid antibodies: a report of two cases. Am J Hematol 1997;54:155–159.

    CrossRef  PubMed  CAS  Google Scholar 

  38. Hohlfeld J, Schneider M, Hein R, et al. Thrombosis of terminal aorta, deep vein thrombosis, recurrent fetal loss, and antiphospholipid antibodies. Case report. Vasa 1996;25:194–199.

    PubMed  CAS  Google Scholar 

  39. Garcia-Torres R, Amigo MC, de la Rosa A, Moron A, Reyes PA. Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings. Lupus 1996;5:56–61.

    PubMed  CAS  Google Scholar 

  40. Lev S, Shoenfeld Y. Cardial valvulopathy in the antiphospholipid antibody syndrome. Clin Rev Allergy Immunol 2002;23:341–348.

    CrossRef  PubMed  Google Scholar 

  41. Ziporen L, Goldberg L, Arad M, et al. Libman-Sacks endocarditis in the antiphospholipid syndrome immunopathologic findings in deformed heart valves. Lupus 1996;5:196–205.

    PubMed  CAS  Google Scholar 

  42. Eiken PW, Edwards WD, Tazelaar HD, McBane RD, Zekr KJ. Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985–2000. Mayo Clin Proc 2001;76:1204–1212.

    CrossRef  PubMed  CAS  Google Scholar 

  43. Borowska-Lehman J, Bakowska A, Michowska M, Rzepko R, Izycka E, Chrostowski L. Antiphospholipid syndrome in systemic lupus erythematosus-immunomorphological study of the central nervous system; case report. Folica Neuropathol 1995;33:231–233.

    CAS  Google Scholar 

  44. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996;93:1579–1587.

    PubMed  CAS  Google Scholar 

  45. Reshetniak TM, Kotel’nikova GP, Fomicheva OA, et al. Cardiological aspects of the antiphospholipid antibody syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid antibody syndrome and systemic lupus erythematosus. Kardiologiia 2002;42:38–43.

    PubMed  CAS  Google Scholar 

  46. Asherson RA, Cervera R. Antiphospholipid antibodies and the lung [editorial]. J Rheumatol 1995;22:62–66.

    PubMed  CAS  Google Scholar 

  47. Falcini F, Taccetti G, Ermini M, Trapani S, Matucci Cerinic M. Catastrophic antiphospholipid antibody syndrome in pediatric systemic lupus erythematosus. J Rheumatol 1997;24:389–392.

    PubMed  CAS  Google Scholar 

  48. Yokoi T, Tomita Y, Fukaya M, Ichihara S, Kakudo K, Takahashi Y. Pulmonary hypertension associated with SLE: predominantly thrombotic arteriopathy accompanied by plexiform lesions. Arch Pathol Lab Med 1998;122:467–470.

    PubMed  CAS  Google Scholar 

  49. Espinoza G, Cervera R, Font J, Asherson RA. The lung in antiphospholipid antibody syndrome. Ann Rheum Dis 2003;61:195–198.

    CrossRef  Google Scholar 

  50. D’Agati V, Kunis C, William G, et al. Anticardiolipin and renal disease-a report of three cases. J Am Soc Nephrol 1980;1:777–784.

    Google Scholar 

  51. Kleinknecht D, Bobrie G, Meyer O, Noël LH, Callard P, Ramdane M. Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant. Nephrol Dial Transplant 1989;4:854–858.

    PubMed  CAS  Google Scholar 

  52. Asherson RA, Hughes GRV, Derksen RHWM. Renal infarction associated with antiphospholipid antibodies in systemic lupus erythematosus and ‘lupus-like’ disease. J Urol 1988;140:1028.

    PubMed  CAS  Google Scholar 

  53. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid antibody syndrome: clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998;77:195–207.

    CrossRef  PubMed  CAS  Google Scholar 

  54. Legerton CW, Leaker B, McGregor A, et al. Insidious loss of renal function in patients with anticardiolipin antibodies and the absence of overt nephritis. Br J Rheumatol 1991;30:422–425.

    Google Scholar 

  55. Cacoub P, Wechsler B, Piette JC, et al. Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis. Clin Exp Rheum 1993;11:479–485.

    CAS  Google Scholar 

  56. Mandreoli M, Zucchelli P. Renal vascular disease in patients with primary antiphospholipid antibodies. Nephrol Dial Transplant 1993;8:1277–1280.

    PubMed  CAS  Google Scholar 

  57. Appel GB, Pirani CL, D’Agati V. Renal vascular complications of systemic lupus erythematosus [editorial]. J Am Soc Nephrol 4:1499–1515.

    Google Scholar 

  58. Amigo MC, Garcia-Torres R, Robles M, Bochicchio T, Reyes PA. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992;19:1181–1185.

    PubMed  CAS  Google Scholar 

  59. Petras T, Rudolph B, Filler G, et al. An adolescent with acute renal failure, thrombocytopenia, and femoral vein thrombosis. Nephrol Dial Transplant 1998;13:480–483.

    PubMed  CAS  Google Scholar 

  60. Strief W, Monagle P, South M, Leaker M, Andrew M. Arterial thrombosis in children. J Pediatrics 1999;134:110–112.

    CrossRef  Google Scholar 

  61. Almeshari K, Alfurayh, Akhtar M. Primary antiphospholipid syndrome and self-limited renal vasculitis during pregnancy: case report and review of the literature. Am J Kidney Dis 1994;24:505–508.

    PubMed  CAS  Google Scholar 

  62. Bhandari S, Harnden P, Brownjohn AM, Turney JH. Association of anticardiolipin antibodies with intra-glomerular thrombi and renal dysfunction in lupus nephritis. QJM 1998;91:401–409.

    CrossRef  PubMed  CAS  Google Scholar 

  63. Lelievre G, Vanhille P. Renal thrombotic microangiopathy in SLE: clinical correlations and long term renal survival. Nephrol Dial Transplant 1998;13:298–304.

    PubMed  Google Scholar 

  64. Griffiths MH, Papadaki L, Neild GH. The renal pathology of primary antiphospholipid antibody syndrome: a distinctive form of endothelial injury. QJM 2000;93:457–467.

    CrossRef  PubMed  CAS  Google Scholar 

  65. Coull BM, Bourdette DN, Goodnight SH, Briley DP, Hart R. Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke 1987;18:1107–1112.

    PubMed  CAS  Google Scholar 

  66. Fulham MJ, Gatenby P, Ruck RR. Focal cerebral ischemia and antiphospholipid antibodies: a case for cardiac embolism. Acta Neurol Scand 1994;90:417–423.

    CrossRef  PubMed  CAS  Google Scholar 

  67. Futrell N, Asherson RA, Lie JT. Probable antiphospholipid syndrome with recanalization of occluded blood vessels mimicking proliferative vasculopathy. Clin Exp Rheum 1994;12:230–231.

    CAS  Google Scholar 

  68. Belmont HM, Abramson SB, Lie JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interaction of inflammatory cells and activated endothelium. Arthritis Rheum 1996;39:9–22.

    PubMed  CAS  Google Scholar 

  69. Ellison D, Gatter K, Heryet A, Esiri M. Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus. J Clin Pathol 1993;46:37–40.

    PubMed  CAS  Google Scholar 

  70. Olguin-Ortega L, Jara LJ, Becerra M, et al. Neurological involvement as a poor prognostic factor in catastrophic antiphospholipid antibody syndrome: autopsy findings in 12 cases. Lupus 2003;12:93–98.

    CrossRef  PubMed  CAS  Google Scholar 

  71. Asherson R, Morgan S, Harris E, et al. Arterial occlusion causing large bowel infarction: a reflection of clotting diathesis in SLE. Clin Rheumatol 1986;5:102–106.

    CrossRef  PubMed  CAS  Google Scholar 

  72. Kallman DR, Khan A, Romain PL, Nompleggi DJ. Giant gastric ulceration associated with antiphospholipid antibody syndrome. Am J Gastroenterol 1996;91:1244–1247.

    Google Scholar 

  73. Dessailloud R, Papo T, Vaneecloo S, Gamblin C, Vanhille P, Piette JC. Acalculous ischemic gallbladder necrosis in the catastrophic antiphospholipid syndrome. Arthritis Rheum 1998;41:1318–1320.

    CrossRef  PubMed  CAS  Google Scholar 

  74. Ahmed N, Miller NS, Bagati R, Weinstein A, Jelinek JS, McCarty GA. Abdominal pain in a young woman with systemic lupus erythematosus — a paradigm shift from the 1980s to 2004? Proceedings of the DC Rheumatism Society Fellows’ Forum, Washington Hospital Center/Georgetown University Division of Rheumatology and Immunology, 2004.

    Google Scholar 

  75. Sanchez-Guerrero J, Reyes E, Alarcon-Segovia D. Primary antiphospholipid antibody syndrome as a cause of intestinal infarction. J Rheumatol 1992;19:623–627.

    PubMed  CAS  Google Scholar 

  76. Espinosa G, Santos E, Cervera R, et al. Adrenal involvement in the antiphospholipid antibody syndrome: clinical and immunologic characteristics of 86 patients. Medicine (Baltimore) 2003;82:106–118.

    CrossRef  PubMed  Google Scholar 

  77. Brooks MD, Fletcher MS, Melcher DH. Venous thrombosis of the bladder associated with antiphospholipid syndrome. J R Soc Med 1994;87:633–634.

    PubMed  CAS  Google Scholar 

  78. Bendon RW, Wilson J, Getahun B, van der Bel-Kahn J. A maternal death due to thrombotic disease associated with anticardiolipin antibody. Arch Pathol Lab Med 1987;111:370–373.

    PubMed  CAS  Google Scholar 

  79. Giron-Gonzalez JA. Platelet and endothelial cell activation are requisites for the development of antiphospholipid antibody syndrome. Ann Rheum Dis 2004;63:600–601.

    CrossRef  PubMed  Google Scholar 

  80. Connor P, Hunt BJ. Cerebral haemostasis and antiphospholiipid antibodies. Lupus 2003;12:929–934.

    CrossRef  PubMed  CAS  Google Scholar 

  81. Arfors L, Lefvert VK. Enrichment of antibodies against phospholipids in circulating immune complexes (CIC) in the anti-phospholipid syndrome (APLS). Clin Exp Immunol 1996;108:47–51.

    CrossRef  Google Scholar 

  82. McClain MT, Arbuckle MR, Heinlen LD, et al. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum 2004;50:1226–1232.

    CrossRef  PubMed  Google Scholar 

  83. Miret C, Cervera R, Reverter JC, et al. Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient’ seronegative’ antiphospholipid syndrome? Clin Exp Rheumatol 1997;15:541–544.

    PubMed  CAS  Google Scholar 

  84. Shoenfeld Y. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Cleve Clin J Med 2002;69(suppl 2):SII65–SII67.

    CrossRef  PubMed  Google Scholar 

  85. Stone S, Hunt BJ, Seed PT, Parmara K, Khamashta MA, Poston L. Longitudinal evaluation of markers of endothelial cell dysfunction and hemostatis in treated antiphospholipid antibody syndrome and in health pregnancy. Am J Obstet Gynecol 2003;188:454–460.

    CrossRef  PubMed  CAS  Google Scholar 

  86. Pierangeli SS, Liu X, Espinola R, et al. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models. Thromb Haemost 2000;84:388–395.

    PubMed  CAS  Google Scholar 

  87. Rand JR, Wu XX, Quinn AS, et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipids bilayers; evidence from atomic force microscopy and functional assay. Am J Pathol 2003;163:1193–2000.

    PubMed  CAS  Google Scholar 

  88. Cho CS, Cho ML, Chen PP, et al. Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells. J Immunol 2002;168:4209–4218.

    PubMed  CAS  Google Scholar 

  89. Raschi E, Testoni C, Bosisio D, et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003;109:3495–3500.

    CrossRef  CAS  Google Scholar 

  90. Matsurra E, Kpbayashi K, Koike T, Shoenfeld Y, Khamashta MA, Hughes GR. Oxidized low density lipoprotein as a risk factor for thrombosis in antiphospholipid antibody syndrome. Lupus 2003;12:550–554.

    CrossRef  Google Scholar 

  91. Merrill JT. The antiphospholipid ntibody syndrome and atherosclerosis: clue to pathogenesis. Curr Rheumatol Rep 2003;5:401–406.

    PubMed  Google Scholar 

  92. Zhao Y, Rumold R, Zhu M, et al. An IgG antiprothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times. Arthritis Rheum 1999;42:2132–2138.

    CrossRef  PubMed  CAS  Google Scholar 

  93. Mackworth-Young CG. Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol 2004;136:393–401.

    CrossRef  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

McCarty, G.A. (2006). Vascular Pathology of Antiphospholipid Antibody Syndrome. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/1-84628-009-5_28

Download citation

  • DOI: https://doi.org/10.1007/1-84628-009-5_28

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-873-2

  • Online ISBN: 978-1-84628-009-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics